An observational study in Cardiac Arrest, sponsored by University of Milano Bicocca. Status unknown at 1 site in Italy. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2011-08-04.
Sponsored by University of Milano Bicocca · Observational
Extracorporeal membrane oxygenation (ECMO) support has been suggested to improve the survival rate in patients with refractory cardiac arrest (CA). Recent studies have also highlighted the potential early application of this method in improving the prognosis of prolonged cardiac arrest both for in hospital CA (INHCA) and out of hospital CA (OHCA). The rationale for use of ECMO in these patients is to optimize early perfusion of vital organs, curing the cause of CA and waiting for the recovery of the injured myocardium. The investigators have created a flow-chart to decide which patients are eligible. The aims of this study are to evaluate if, with this flow-chart, the investigators are able to detect which patients have more probability of survival.
966 studies on the registry are indexed under Heart Arrest; 226 are open to participants now.
This study's planned enrollment of 40 is below the median of 200 across 382 observational studies indexed under Heart Arrest.
Browse Heart Arrest studies →University of Milano Bicocca is the lead sponsor of 124 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adults 18-75 years old, community sample
Exclusion Criteria:
All patients have to start ECMO under CPR, by insertion of peripheral VA cannulas.
Procedure: ECMO
Insertion of peripheral Veno-Arterious ECMO, subsequent therapeutic hypothermia
28 days survival
Time frame: 28 days
Neurologic recovery
Neurologic recovery defined as minimal neurologic impairment according to the Glasgow-Pittsburgh cerebral performance categories score ≤ 2.
Time frame: 28 days
Cardiac recovery
Measured by echocardiography
Time frame: 28 days
Six months survival with minimal neurologic impairment
survival with minimal neurologic impairment according to the Glasgow-Pittsburgh cerebral performance categories score ≤ 2.
Time frame: 180 days
This study is status unknown, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Milano Bicocca